5 Results for "

human Granzyme B

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "human Granzyme B" in MCE Product Catalog:

Cat. No.: HY-P703940
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: GZMB; Granzyme B (Granzyme 2, Cytotoxic T-Lymphocyte-Associated Serine Esterase 1); Prev. CTLA1; Cytotoxic Serine Protease B; Prev. CSPB; human Lymphocyte Protein; CTSGL1; Fragmentin-2; CGL1; C11; SECT; Cytotoxic T-Lymphocyte-Associated Serine Esterase 1
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P86300
Synonyms: Granzyme B; C11; CTLA-1; Cathepsin G-like 1; CTSGL1; Cytotoxic T-lymphocyte proteinase 2; Lymphocyte protease; Fragmentin-2; Granzyme-2; human lymphocyte protein; HLP; SECT; T-cell serine protease 1-3E;

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF, IP, ELISA

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P992021

Research Areas:  

Cancer

WM-A1-3389 is an anti-human IGSF1monoclonal antibody and tumor growth inhibitor. WM-A1-3389 specifically binds to the C-terminus of IGSF1, increases secretion of Granzyme B, IFN?γ, and TNF?α, and inhibits growth of colon cancer or biliary tract cancer in xenogeneic or allogeneic mouse implantation models. WM-A1-3389 can be used for the research of colon cancer, biliary tract cancer, and head and neck cancer .
loading...
    loading...
Cat. No.: HY-P992524
Target:  

CD3

Research Areas:  

Cancer

PF-07260437 is a bispecific monoclonal antibody targeting B7-H4 and CD3, with Kd values of 63.5 nM and 66.75 nM against human and cynomolgus monkey CD3, respectively. PF-07260437 simultaneously binds B7-H4 on tumor cells and the CD3ε subunit in the T cell receptor complex, forming a tumor cell-bispecific antibody-T cell trimer. This process establishes an immune synapse and initiates non-MHC-dependent T cell activation, proliferation, and release of cytotoxic molecules such as granzyme B to kill tumor cells. PF-07260437 can be used in research related to advanced or metastatic breast cancer, ovarian cancer, and endometrial cancer .
loading...
    loading...
Cat. No.: HY-184689
CAS No.: 1311892-52-0
Target:  

LILRB

Research Areas:  

Cancer

ORS-14 is a LILRB4/ILT3 ligand with a Kd of 85.2 nM for human receptors. ORS-14 blocks SCG2-mediated LILRB4 signaling pathway, reverses SCG2-mediated immunosuppression, restores cytokine production, reduces tumor cell viability, recovers cytotoxic T cell function, and increases the frequency of granzyme B + CD8 + T cells. ORS-14 can be used in research related to colorectal cancer and acute myeloid leukemia .
loading...
    loading...